Carlsmed Achieves FDA Approval for aprevo® Cervical Device
Carlsmed, Inc., a pioneering MedTech company specializing in AI-enabled personalized spine surgery, proudly announces its recent achievement: FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This landmark approval signifies a major advancement in personalized spine surgery, reinforcing Carlsmed’s dedication to enhancing surgical precision and outcomes tailored for each patient.
Breakthrough Device Designation Recognition
The FDA had previously granted a Breakthrough Device designation for the aprevo® technology, which is specifically designed for treating patients with cervical spine disease. This recognition underscores the system's potential in addressing unmet clinical needs, ultimately aiming to deliver superior patient care. Carlsmed's current offerings also include a suite of aprevo® interbody fusion devices, which are already available for treating lumbar spine disease in the United States.
Significance of the 510(k) Clearance
“The clearance of our 510(k) application is a monumental milestone,” stated Mike Cordonnier, the Chairman and CEO of Carlsmed. “With over 350,000 cervical fusion surgeries conducted each year in the U.S., the introduction of the aprevo® Cervical ACDF Interbody System establishes a new standard that prioritizes improved patient outcomes.”
Innovative Design Tailored to Needs
The aprevo® system is meticulously designed to fit the unique anatomical and procedural requirements of individual patients. Clinical studies have highlighted that personalized interbody devices significantly enhance patient outcomes compared to traditional fusion techniques. Carlsmed's innovative technology harnesses proprietary AI-driven surgical planning software and advanced digital production capabilities to create these customized fusion devices, allowing for delivery in under two weeks.
Expert Insights on Personalized Surgery
Dr. Joseph Osorio, a renowned neurosurgeon at UC San Diego, expressed the importance of such innovative solutions in modern-day spinal surgeries. “Personalized devices like aprevo® enable surgeons to tackle the specific anatomical challenges of each patient. The availability of this technology for cervical fusions represents a substantial leap forward in spinal surgery, moving away from the limitations of generic implants towards tailored solutions that improve alignment and surface coverage—elements crucial for successful outcomes.”
The Future of Carlsmed’s Product Portfolio
Looking ahead, Carlsmed aims to commercially launch the aprevo® Cervical ACDF Interbody System in the United States by 2025. This expansion reflects the company’s commitment to fortifying its position as a leader in the personalized spine surgery segment, broadening its innovative product range.
About Carlsmed
Carlsmed stands at the forefront of medical technology, particularly within the realm of personalized spine surgery. The company is dedicated to transforming the standard of care in this field through advanced solutions tailored specifically to the needs of each individual patient. The aprevo® Technology Platform merges cutting-edge AI-driven software with customized fusion devices, ultimately elevating surgical procedures, enhancing patient experiences, and minimizing complications. For more information about the services they provide, please visit carlsmed.com.
Frequently Asked Questions
What is the aprevo® Cervical ACDF Interbody System?
The aprevo® Cervical ACDF Interbody System is a personalized spinal device designed to enhance surgical outcomes for cervical fusion surgeries.
Who is the CEO of Carlsmed?
Mike Cordonnier serves as the Chairman and CEO of Carlsmed.
When will the aprevo® system be launched commercially?
Carlsmed plans to launch the aprevo® Cervical ACDF Interbody System in the U.S. in 2025.
What is unique about the aprevo® technology?
It utilizes AI-driven surgical planning and customization to create patient-specific fusion implants, significantly improving surgical outcomes.
Where can I find more information about Carlsmed?
You can visit their website at carlsmed.com for more details.
